Traditional Chinese medicine for treating chronic obstructive pulmonary disease in stable stage

Abstract

The invention discloses a traditional Chinese medicine for treating chronic obstructive pulmonary disease in a stable stage and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine aims at solving the problems of repeated attacks, progressive deterioration and poor clinical efficacy of patients suffering from the chronic obstructive pulmonary disease. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 10-20 parts of roots of rhodiola rosea, 10-20 parts of American ginseng, 20-50 parts of radix hedysari, 10-20 parts of stemona japonica, 10-20 parts of white mulberry root-bark, 10-30 parts of fresh rehmannia roots, 10-20 parts of Chinese angelica, 20-50 parts of lily bulbs, 10-20 parts of ophiopogon japonicas, 10-15 parts of Chinese magnoliavine fruits, 10-15 parts of ginkgo nuts, 10-20 parts of pinellia ternate, 10-20 parts of poria cocos, 10-20 parts of unibract fritillary bulbs, 10-20 parts of stir-fried perilla seeds, 10-15 parts of sweet pepperweed seeds, 10-20 parts of polygonatum sibiricum, 10-20 parts of short-horned epimedium herbs, 5-10 parts of Szechwan cassia twigs, 5-10 parts of ephedra herbs, 5-10 parts of manchurian wildginger, 5-10 parts of Chinese eaglewood, 10-20 parts of dried tangerine peels, 10-20 parts of fructus lycii, 10-20 parts of panax notoginseng, 10- 20 parts of prepared liquorice roots, 5- 10 parts of dried human placenta, 10-20 parts of tatarian aster roots, 5- 10 parts of leeches, 3- 10 parts of caterpillar fungi and a pair of geckoes. The traditional Chinese medicine has the effects of tonifying the spleen, nourishing the lung, tonifying the kidney, relieving asthma, eliminating turbid phlegm, removing blood stasis, promoting coronary circulation and improving health.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease in the stable phase. Background technique [0002] Chronic obstructive pulmonary disease is a very common chronic respiratory disease, the main features are long-term repeated cough, expectoration, wheezing and acute respiratory infection. The disease is progressive. Pulmonary function is obviously abnormal; abnormal lung function is characterized by limited expiratory airflow, due to the narrowing and obstruction of the bronchi, and the reduction of the elastic recoil force of the lungs, when exhaling forcefully, the expiratory airflow velocity is greatly slowed down. Therefore, the World Health Organization proposes that the disease is characterized by a disease characterized by airflow limitation that is not fully reversible and progressive, and its onset is relat...

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to provide a traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease in the stable phase, so as to solve the problems of repeated attacks, progressive aggravation and poor clinical curative effect in patients with chronic obstructive pulmonary disease

Images